Toward improved models of human cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Toward improved models of human cancer

Published:2021-03-01 Issue:1 Volume:5 Page:010901
ISSN:2473-2877
Container-title:APL Bioengineering
language:en
Short-container-title:APL Bioengineering

Author:

Welm Bryan E.¹,Vaklavas Christos²^ORCID,Welm Alana L.³^ORCID

Affiliation:

1. Department of Surgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA

2. Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA

3. Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA

Funder

National Cancer Institute

Department of Defense

Publisher

AIP Publishing

Subject

Biomedical Engineering,Biomaterials,Biophysics,Bioengineering

Link

http://aip.scitation.org/doi/pdf/10.1063/5.0030534

Reference33 articles.

1. Concepts in Cancer Modeling: A Brief History

2. Organotypic cancer tissue models for drug screening: 3D constructs, bioprinting and microfluidic chips

3. Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies

4. Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab

5. Lessons from patient-derived xenografts for better in vitro modeling of human cancer

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomimetic Design of Peptide Inhibitor to Block CD47/SIRPα Interactions;Langmuir;2023-12-01

2. Hematogenous metastasis and tumor dormancy as concepts or dogma? The continuum of vessel co-option and angiotropic extravascular migratory metastasis as an alternative;Frontiers in Oncology;2022-10-11

3. Editorial Series conclusion and journal outlook;APL Bioengineering;2022-09-01

4. Multiparametric quantitative phase imaging for real-time, single cell, drug screening in breast cancer;Communications Biology;2022-08-08

5. A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in NRAS Mutant Melanoma;Cancer Research;2022-06-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3